Edit Module

Elanco Launches Flea Control Product Just For Cats



Published:

Elanco Companion Animal Health has launched Assurity, a topical flea treatment developed specifically for cats. Most other feline flea treatments share canine formulations, according to the Indianapolis-based company.

The active ingredient is spinetoram, registered by the U.S. Environmental Protection Agency in 2007 for use on a variety of fruits and tree nuts. In regards to agricultural use, spinetoram has a lower environmental impact than many current insecticides because both its use rate and toxicity to non-target species are low, according to Elanco.

Assurity is said to be the first flea control product using this active ingredient.

Elanco reported that Assurity kills 98 percent to 100 percent of fleas within 12 hours, killing fleas before they can lay eggs. It is 100 percent effective for a full month, according to the company.

The product, only available through licensed veterinarians, comes in a six-dose package and a single-dose package. One dose treats all sizes of cats and kittens, eight weeks of age and older, according to Elanco.

“To reinforce dispensing within the context of a valid veterinarian/client/patient relationship, all boxes and cartons of Assurity contain a unique product tracking code,” said Steve Connell, DVM, director of technical, academic and consumer services for Companion Animal Health at Elanco. “This code helps ensure product quality and integrity.”

Elanco encourages pet owners to always read, understand and follow label and use directions.

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Where Did All the Vet Techs Go?

NATVA's 2016 survey reveals the challenges vet techs face, which leads to high turnover.

Mazuri Launches Veterinarian Resource Center Facebook Page

The page will provide exotic animal practitioners articles, facts, success stories, management tips.

NIH Issues Grant to Further Canine Cancer Research

The grant, awarded to various colleges and groups, will fund a study aimed at understanding the interactions between cancer and the immune system in dogs with naturally occurring tumors. The researchers will then apply that knowledge to the understanding of human cancer.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module